2018–19 Departmental Plan: Planned evaluation coverage over the next five fiscal years

Planned evaluation coverage, 2018–19 to 2022–23
Program Last evaluation Evaluations planned in the next 5 years Fiscal year of approval 2018–19 Program spending covered by the planned evaluation
(dollars)
2018–19 Program spending covered by all planned evaluations
(dollars)
2018–19 Total program spending (dollars) Rationale for not evaluating Program or spending

Investigator-Initiated Research

Evaluation of the Open Operating Grants Program 2012–13

Operating Support Program Evaluation

2018–19

563,547,506

704,837,197

709,160,260

The components of the program not to be evaluated have low materiality, are not ongoing and/or were evaluated within the last five-year period.

Canada Excellence Research Chairs Evaluation 2014–15

Canada Excellence Research Chairs Evaluation

2019–20

4,200,000

Not applicable

Canada First Research Excellence Fund Evaluation

2019–20

43,803,273

Canada Research Chairs Program Evaluation 2016–17

Canada Research Chairs Program Evaluation

2021–22

93,286,418

Training and Career Support

Evaluation of CIHR Salary/Career Award Programs 2012–13

Evaluation of the Training and Career Support Program

2018–19

30,891,956

65,885,297

65,885,297

Not applicable

Evaluation of the Vanier Graduate Scholarships Program 2014–15

Evaluation of the Vanier Graduate Scholarships Program

2019–20

8,911,505

Evaluation of the Banting Postdoctoral Fellowships Program 2014–15

Evaluation of the Banting Postdoctoral Fellowships Program

2019–20

3,402,856

Evaluation of the Canada Graduate Scholarships Program 2016–17

Evaluation of the Canada Graduate Scholarships Program

2021–22

22,678,980

Research in Priority Areas

Not applicable

Evaluation of the Dementia Research Strategy

2018–19

4,938,075

233,144,226

299,964,368

The components of the program not to be evaluated have low materiality, are not ongoing and/or were evaluated within the last five-year period.

Not applicable

Evaluation of the Canadian Longitudinal Study on Aging

2018–19

7,204,586

Evaluation of the Collaborative Health Research Projects Program 2013–14

Evaluation of the Collaborative Health Research Projects Program

2018–19

10,336,981

Horizontal Evaluation of the Federal Initiative to Address HIV/AIDS in Canada 2014–15

Horizontal Evaluation of the Federal Initiative to Address HIV/AIDS in Canada

2018–19

22,483,937

CIHR 2011 International Review 2011–12

Review of the Institute of Infection and Immunity

2018–19

3,213,831

CIHR 2011 International Review 2011–12

Review of the Institute of Health Services and Policy Research

2018–19

5,884,221

CIHR 2011 International Review 2011–12

Review of the Institute of Gender and Health

2018–19

6,715,497

CIHR 2011 International Review 2011–12

Review of the Institute of Aging

2018–19

5,832,119

Evaluation of the College and Community Innovation Program 2012–13

Evaluation of the College and Community Innovation Program

2018–19

210,188

Evaluation of the Drug Safety and Effectiveness Network 2014–15

Evaluation of the Drug Safety and Effectiveness Network

2019–20

7,678,446

CIHR 2011 International Review 2011–12

Review of the Institute of Human Development, Child and Youth Health

2019–20

5,862,038

CIHR 2011 International Review 2011–12

Review of the Institute of Circulatory and Respiratory Health

2019–20

7,228,026

CIHR 2011 International Review 2011–12

Review of the Institute of Population and Public Health

2019–20

5,200,216

Not applicable

Public Health Laboratories Evaluation

2019–20

2,880,855

Not applicable

Evaluation of the Antimicrobial Resistance Initiatives

2020–21

1,846,393

CIHR 2011 International Review 2011–12

Review of the Institute of Aboriginal Peoples' Health

2020–21

6,599,996

Evaluation of the Institute of Neurosciences, Mental Health and Addiction 2016–17

Review of the Institute of Neurosciences, Mental Health and Addiction

2020–21

4,941,889

Evaluation of the Institute of Musculoskeletal Health and Arthritis 2016–17

Review of the Institute of Musculoskeletal Health and Arthritis

2020–21

5,575,675

Evaluation of the Business-Led Networks of Centres of Excellence Program 2015–16

Evaluation of the Business-Led Networks of Centres of Excellence Program

2020–21

1,737,000

Evaluation of the Networks of Centres of Excellence Program 2015–16

Evaluation of the Networks of Centres of Excellence Program

2020–21

21,740,400

Evaluation of the Institute of Cancer Research (2017–18)

Review of the Institute of Cancer Research

2021–22

6,701,462

Evaluation of the Institute of Nutrition, Metabolism and Diabetes  2017–18

Review of the Institute of Nutrition, Metabolism and Diabetes

2021–22

6,023,316

Evaluation of the Strategy for Patient Orientated Research 2016–17

Evaluation of the Strategy for Patient Orientated Research

2021–22

61,187,409

Review of the Institute of Genetics 2017–18

Review of the Institute of Genetics

2022–23

3,275,378

Horizontal Evaluation of the National Anti-Drug Strategy 2017–18

Horizontal Evaluation of the Canadian Drugs and Substances Strategy (formerly known as National Anti-Drug Strategy)

2022–23

4,190,286

Evaluation of the Centres of Excellence for Commercialization and Research 2017–18

Evaluation of the Centres of Excellence for Commercialization and Research

2022–23

13,194,408

Evaluation of Gairdner 2017–18

Evaluation of Gairdner

2022–23

461,598

Internal Services

Not applicable

Not applicable

Not applicable

0

0

27,423,337

Historically at CIHR, internal services have not been evaluated as separate entities but risks associated with the ten services are considered in the conduct of the evaluations of programs, initiatives and institutes as they relate to the evaluation issues of design and delivery, and performance (effectiveness, efficiency and economy).

Total

Not applicable

Not applicable

Not applicable

Not applicable

1,003,866,720

1,102,433,262

Date modified: